A&O Shearman advises on the financing for TPG-led take-private of Kangji Medical

Kangji Medical, headquartered in the PRC, is a leading medical device manufacturer listed on the Hong Kong Stock Exchange. The company specializes in designing and producing minimally invasive surgical instruments, which are distributed globally. The proposed take-private transaction values Kangji Medical at approximately HKD11.17 billion (about USD1.42 bn).

The transaction team was led by Hong Kong-based leveraged finance partner Daniel Tan, supported by senior associate Tiffany Tam and trainee Kevin Lo. Beijing based partner Yvonne Ho and China associate Ivan Zhang provided additional support. The Hong Kong M&A team, comprising partners Lina Lee, Jonathan Hsui, and senior associate Michelle Tsang advised on the Hong Kong public-to-private corporate aspects of the financing, highlighting the firm’s cross-office collaboration and multi-disciplinary expertise.